United Therapeutics (UTHR) Tops Q2 EPS by 82c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/30/2026
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil jumps 2%, settles at 6-month highs on fears of escalation in Iran
Tweet
Share
E-mailGet Alerts UTHR Hot Sheet
Price: $598.72 +0.87%
Revenue Growth %: -1.8%
Financial Fact:
Total revenues: 408.2M
Today's EPS Names:
OPY, BNCC, ZVOI, More
Revenue Growth %: -1.8%
Financial Fact:
Total revenues: 408.2M
Today's EPS Names:
OPY, BNCC, ZVOI, More
Join SI Premium – FREE
United Therapeutics (NASDAQ: UTHR) reported Q2 EPS of $3.68, $0.82 better than the analyst estimate of $2.86. Revenue for the quarter came in at $362 million versus the consensus estimate of $339.97 million.
For earnings history and earnings-related data on United Therapeutics (UTHR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Evercose ISI downgrades Reddit, says monetization may not offset traffic weakness
- United Therapeutics Corp. (UTHR) PT Raised to $850 at Cantor Fitzgerald
- Stifel on FedEx Freight (FDXF): 'Enters Its Post-Breakup Era - Time to Hit the Gym and Focus on Itself'
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
